🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

👉Isolated cases of pharyngeal gonorrhoea resistant to both ceftriaxone and azithromycin reported in the UK since 2016. 👉these cases are likely to be the tip of the global iceberg detected due to stringent surveillance and treatment protocols in the UK 👏 ClaireDewsnap(She/her)

Although #PrEP use has increased, disparities remain. To #EndHIVEpidemic, we need to ensure equal access to #HIV prevention and care for everyone.

We are actively recruiting for a one-year clinical (non-ACGME accredited) career development position in Transplant Infectious Diseases during academic year 2023-2024! Check out the posting here: recruit.apo.ucla.edu/JPF08505

If we give people with tuberculosis food baskets, what's the impact? Better nutrition in contacts of patients with TB reduced incidence infectious TB by nearly 50%! Amazing RATIONS trial in The Lancet & The Lancet Global Health today Anurag Bhargava Madhavi Bhargava Soumya Swaminathan DDG - TB | #TBMuktBharat et al

Great work led by Jon Baghdadi

Nice to see some UCLA Pathology #ClinicMicro group here! They've been working to build #NGS pipelines at the lab and also doing some great teaching on #WGS and #genomics analyses. UCLA Multicampus ID Fellowship

"People have tended to focus on #AMR as a market failure problem" says Seamus O'Brien 💙 It is in fact also a #publichealth failure and one that needs to be addressed urgently 📢 Read more in The Bulletin of the World Health Organization article on #antibacterial innovation 👇 ncbi.nlm.nih.gov/pmc/articles/P…

#GlobalHealth Fellowship alert! 📣 Fulbright-Fogarty Fellowships in Public Health open to advanced medical and Ph.D. students interested in global health. Info: go.nih.gov/FulbrightFogar… Deadline: October 10, 2023 The Fulbright Program

Our awesome county hospital Olive View UCLA is looking for an ID physician to lead Infection Control and participate in the clinical and academic activities of the section! More info here: Infection Prevention Physician Specialist (OVMC) g.co/kgs/yMpM8H

#PrEP reduces anxiety, increases intimacy and leads to more pleasurable sex, but these values-based outcomes are neglected in PrEP resources. In The Lancet HIV we argue for better integration of potential user-reported benefits in PrEP training & guidelines authors.elsevier.com/a/1hZac8MsVoa8…

Our latest newsletter focuses on sexual health in older adults, including the Sexual Health in Older Adults Research (SHOAR) project which explores sexual health needs among older adults, including those with disabilities. Read the newsletter and subscribe here: us19.campaign-archive.com/home/?u=95833d…

Many states have done a good job of reducing barriers to Hep C treatment; yet only 20% treated within 6 months; 35% overall. Providers must ensure newly + get treated. Why don’t they?

Syphilis review in The Lancet from Drs. Peeling, Mabey, Garcia, and Chen. Well worth reading! So much unfinished work in this field. Institute for Global Health & Infectious Diseases London School of Hygiene & Tropical Medicine Michael Marks (no paywall for first 50 ppl): authors.elsevier.com/a/1hSCSV-4XHHqu

Chelsea Shover, PhD (Chelsea L. Shover, PhD), from UCLA_GIMHSR, has been at the forefront of researching the prevalence of counterfeit pills in Mexican pharmacies. Read the latest in her interview with the Los Angeles Times. latimes.com/world-nation/s…

Our team at GaDeptPublicHealth is excited to announce that effective 8/14/2023, care providers will be able to prescribe Hepatitis C medications for their patients under ADAP without the need for Prior Approval Carlos del Rio @Armstrws Melanie Thompson David Holland, MD, MHS Laila Woc-Colburn, MD Jonathan Colasanti

🔈 Opening soon! Antimicrobial Resistance 2024! #AMR2024 Join us to explore the importance of genomic data for tackling #AntimicrobialResistance🔬🧬🦠💪🏾 Email us to receive e-updates about this conference: 📩[email protected] #AcademicChatter #PhDlife

#PrEP is a powerful tool for #HIV prevention Still, too many barriers to PrEP exist for too many people. Sometimes, the barriers are medical providers Improving access to PrEP is critical. Greatly appreciate Juan Michael Porter II for discussing a few (of the many) ways to ⬇️ barriers

Our meta-analysis of #HCV in #PrEP users now available open access in Open Forum Infectious Diseases. We found lower HCV incidence in contexts where HCV #DAAs have been implemented at-scale - indicative of HCV treatment as prevention among gay and bisexual men.

📣The Lancet Infectious Diseases: Largest global cohort of #mpox repeat infections & infections after vaccination. While epi similar, infections appear to be less severe with fewer complications. Amazing collab w/ Chloe Orkin Jason & SHARE Collaborative team! thelancet.com/journals/lanin…

In collaboration with UK Health Security Agency our study on genomic epidemiology #Syphilis is now out The Lancet Microbe shorturl.at/jnvS1 We found evidence for separation of sub-lineages by HIV status & sexual orientation consistent with distinct sexual networks 1/n